<DOC>
	<DOC>NCT00240279</DOC>
	<brief_summary>To investigate the effect of rosuvastatin compared to placebo on the aortic stiffness in hemodialysis patients as measured by pulse wave velocity (at 3, 6 and 12 months)</brief_summary>
	<brief_title>The Effect of Rosuvastatin on Aortic Stiffness in Hemodialysis Patients in the AURORA Study</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Signed informed consent, between 50 and 80 years of age, end stage renal failure patients receiving hemodialysis Received statins within past 6 months, a clear indication for use of lipid altering drug, contra indication for lipid altering drug, history of statin induced myopathy items in very</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>high blood cholesterol levels</keyword>
</DOC>